Evidence map›Paper›PMID 39054648›Full record

ArticleThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2024

Poly(Ethylene Glycols) to Facilitate Celloidin Removal for Immunohistochemical Studies on Archival Human Brain and Temporal Bone Sections.

David Bächinger, Jennifer T O'Malley, Morris Wolf, Stephane Bérnhard, M Charles Liberman, Mark W Tibbitt, Andreas H Eckhard

Abstract read
In one paragraph

Article in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Digital Printing of Photoreversible Protective Films.Macromolecular rapid communications · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David BächingerDepartment of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland; University of Zurich, Zurich, Switzerland.ORCID 0000-0002-6336-494X
Jennifer T O'MalleyOtopathology Laboratory, Department of Otolaryngology, Massachusetts Eye and Ear, Boston, Massachusetts.
Morris WolfMacromolecular Engineering Laboratory, Institute of Energy and Process Engineering, Department of Mechanical and Process Engineering, ETH Zurich, Zurich, Switzerland.ORCID 0000-0002-1328-1345
Stephane BérnhardMacromolecular Engineering Laboratory, Institute of Energy and Process Engineering, Department of Mechanical and Process Engineering, ETH Zurich, Zurich, Switzerland.ORCID 0000-0002-6534-6905
M Charles LibermanOtopathology Laboratory, Department of Otolaryngology, Massachusetts Eye and Ear, Boston, Massachusetts.
Mark W TibbittMacromolecular Engineering Laboratory, Institute of Energy and Process Engineering, Department of Mechanical and Process Engineering, ETH Zurich, Zurich, Switzerland.ORCID 0000-0002-4917-7187
Andreas H EckhardOtopathology Laboratory, Department of Otolaryngology, Massachusetts Eye and Ear, Boston, Massachusetts.

Funding

Massachusetts Eye and Ear/ Harvard Initiative for the NIDCD National Human Ear Resource NetworkU24DC020849 · NIDCD · MASSACHUSETTS EYE AND EAR INFIRMARY · PI M. Charles Liberman, Alicia M Quesnel · 2022 to 2026
$3.2M
NIDCD NIH HHS U24 DC020849
6 · The paper itself

Abstract

Pathology repositories worldwide store millions of celloidin-processed human brain and temporal bone (TB) sections vital for studying central nervous system diseases and sensory organs. However, accessing these sections for modern molecular-pathological research, like immunohistochemistry, is hindered by the challenge of removing celloidin without damaging tissue. In this study, we explored the use of polyethylene glycols (PEGs), a class of non-hazardous, ethylene glycol oligomers, combined with an improved section mounting technique, to gently and effectively dissolve celloidin from sections archived for up to 40 years. Optimizing our protocol involved exploring celloidin dissolution kinetics in PEGs of varying molecular weights and terminations, as well as different temperatures. Low molecular weight PEGs, particularly PEG 200, were the most efficient celloidin solvent. Nuclear magnetic resonance (NMR) spectroscopy of celloidin-PEG 200 dissolution products revealed no chemical alterations, suggesting pure solvation without chemical modification. Because the solvation of celloidin in PEG was inhibited by proteins, we further developed a protein-free mounting protocol allowing complete celloidin removal in 30 to 60 minutes by immersing in PEG 200. In summary, our approach overcomes major methodological hurdles, rendering decades-old archival celloidin sections viable for immunohistochemical and other molecular biological techniques, while enhancing safety and workflow efficiency.

Indexed as

BrainImmunohistochemistryPolyethylene GlycolsHumansPolyethylene GlycolsDNAimmunohistochemistryinner earsodium methoxide

Identifiers

PMID39054648
PMCPMC11308191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.